$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Lipid droplets (LDs) are ubiquitous intracellular fat bodies composed of a core of neutral lipids, mainly TAGs and sterol esters (SE). The core is surrounded by a monolayer of phospholipids that interacts with proteins like perilipin and enzymes involved in the synthesis of neutral lipids, such as the diacylglycerol acyl-transferase, acetyl-CoA carboxylase and acyl-CoA synthase1. Due to its dynamic behavior, the phospholipid monolayer also contains triacylglycerol lipases that hydrolyze TAGs and SE2. Depending on the cell type and organism, stored neutral lipids can be used to generate energy, or synthesize phospholipids and signaling molecules. In yeast and other fungi, the content of LDs changes in response to variations in the nitrogen/carbon ratio in the culture media, indicating that decreased nitrogen availability might be the key to increase neutral lipid production3,4,5. The production of high amounts of TAGs in yeast has a potential use in biotechnology as source of biofuels and in the food industry. Some stored lipids contain high proportions of polyunsaturated fatty acids, like omega 3 and omega 6, with nutritional and dietary importance 6,7,8,9,10,11. LDs of mammalian cells, including human cells, also contain TAGs and cholesterol esters. The phospholipid monolayer interacts with the mammalian homologous of the proteins described in the yeast LDs, and with an additional protein, perilipin, which is absent in S. cerevisiae12. One proposed role for the phospholipid monolayer and its associated proteins is to stabilize the LDs structure and to allow the interaction of LDs with organelles as mitochondria, endoplasmic reticulum, peroxisomes, and vacuoles, mainly for lipid exchange 13,14. Interestingly, in humans, LDs appear to be involved in pathologies like type 2 diabetes, atherosclerosis, steatohepatitis, and coronary heart disease, in which there is an increase in their number 15,16,17. Some types of viruses use LDs as platforms to assemble the virions 2,18,19.
Due to the implications of the LDs in human pathologies and their potential biotechnological use, the exact experimental determination of LDs formation is an important task. This article describes a reliable assay based on the recovery of the fluorescence (LFR) of BODIPY 493/503 (4, 4-difluoro-1, 3, 5, 7, 8-pentamethyl-4-bora-3a, 4a-diaza-s-indacene), to get a relative value of the content of neutral lipids in cells. With this assay, it is possible to follow the dynamics of the accumulation of neutral lipids in fungi like U. maydis and S. cerevisiae, and also in mammalian cells, without the need of lipid extraction 20. The method was applied for the first time in S. cerevisiae to identify the protein phosphatases and kinases involved in the regulation of lipid metabolism. This was possible without lipid extraction or protein purification21,22. LFR also has been used to establish the dynamics of LDs formation in peritoneal macrophages23. The use of BODIPY 493/503 has some advantages over other neutral lipid dyes as Nile Red. BODIPY 493/503 is highly specific for neutral lipids and has a narrow emission spectrum, facilitating the simultaneous detection of signals from dyes like red fluorescent protein or Mito-tracker, when the samples are analyzed by confocal microscopy. Unfortunately, BODIPY 493/503 is sensitive to photobleaching, but this process can be avoided by using an antiquenching reagent during exposure to light24.
To carry out the LFR assay in yeast cells, they are cultured under the desired nutritional conditions, and aliquots are withdrawn at different times. Next, cells are fixed with formaldehyde, which preserves the integrity of LDs for months when cells are stored at 4 °C. Other fixation techniques should be avoided, especially those using methanol or cold acetone, since they lead to the degradation of LDs within the cells24. To measure the LD index, formaldehyde-fixed cells are suspended in water to obtain a defined concentration. Then, they are added to a solution containing the fluorophore BODIPY 493/503 quenched by KI, and when the fluorophore enters the cell and associates with the LDs, there is a recovery of its fluorescence. Concomitant to the fluorescence measurement (485 nm/510 nm), the concentration of cells is quantified by measuring the optical density at 600 nm. Each sample is read four times by adding subsequent 5 µL aliquots of a formaldehyde-fixed cell suspension to the same well. Blanks of fluorescence and absorbance are acquired before the addition of cells. The quality of the fluorescence and the absorbance data are evaluated by determining the linearity of the measurements: if r <0.9, data are discarded. The r value is important because basically the intensity of fluorescence should produce a linear response to increasing cell concentrations. If the cell concentration is too high, the linearity is lost. The LFR assay provides a fast, simple and economic method to select the desired LD phenotype in high-throughput experiments. After selecting the desired conditions, the LD content of individual cells can be studied by confocal microscopy, using the same formaldehyde-fixed cells stained with BODIPY, providing an image of the LDs in the cell. Their TAGs and SE content can now be further analyzed by thin layer chromatography.